Fractyl Health, Inc. reported $93K of revenue over the trailing twelve months. 9 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $93K (to Q4 2024). Net income: −$106M, trailing twelve months to Q2 2026. Free cash flow: −$91M, trailing twelve months to Q4 2025. EPS: −$0.88, trailing twelve months to Q2 2026.

GUTSFractyl Health, Inc.

Healthcare

$0.49-50% 1Y

$0.49

$0.3952 weeks$4.58

GUTS as reported

Fractyl Health, Inc. reported $93K of revenue over the trailing twelve months. 9 reported series are charted on this page, each one as filed.

$93K

Revenue, trailing twelve months · to Q4 2024 · every figure below is as filed, with no scoring applied

Net income: −$106M
Net income · +5.9% year on year · trailing twelve months to Q2 2026
Free cash flow: −$91M
Free cash flow · trailing twelve months to Q4 2025
EPS: −$0.88
EPS · −57% year on year · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for GUTS, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$93K	n/a	Q4 2024 · 6 quarters behind
Net income	−$106M	+5.9%	Q2 2026
EPS	−$0.88	−57%	Q2 2026
Gross margin	59%	n/a	Q4 2024 · 6 quarters behind
Operating margin	−282256%	n/a	Q4 2024 · 6 quarters behind
Net margin	−261997%	n/a	Q4 2024 · 6 quarters behind
ROE	2049%	n/a	Q2 2026
ROA	−115%	n/a	Q2 2026
Free cash flow	−$91M	n/a	Q4 2025

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.